Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Drugs
|
August 3, 2018
Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances
Paolo Sfriso, Sara Bindoli, Paola Galozzi
Autoimmunity Reviews
|
February 23, 2021
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Drugs
|
March 5, 2024
Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Biologics : Targets & Therapy
|
April 28, 2022
Progress in Biological Therapies for Adult-Onset Still's Disease
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Joint Bone Spine
|
January 9, 2023
Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series
Sara Bindoli, Paola Galozzi, Andrea Doria, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
May 27, 2023
JAK inhibitors for the treatment of VEXAS syndrome
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
January 24, 2022
Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review
Sara Bindoli, Alessandro Giollo, Paola Galozzi, et al.
Expert Review of Clinical Immunology
|
January 21, 2020
Canakinumab for the treatment of adult-onset Still's disease
Paolo Sfriso, Sara Bindoli, Andrea Doria, et al.
Frontiers in Pharmacology
|
October 10, 2018
Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease
Paola Galozzi, Chiara Baggio, Sara Bindoli, et al.
Journal of Clinical Medicine
|
April 30, 2021
Autoinflammatory Features in Gouty Arthritis
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Drugs
|
August 3, 2018
Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances
Paolo Sfriso, Sara Bindoli, Paola Galozzi
Autoimmunity Reviews
|
February 23, 2021
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Drugs
|
March 5, 2024
Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Biologics : Targets & Therapy
|
April 28, 2022
Progress in Biological Therapies for Adult-Onset Still's Disease
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Joint Bone Spine
|
January 9, 2023
Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series
Sara Bindoli, Paola Galozzi, Andrea Doria, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
May 27, 2023
JAK inhibitors for the treatment of VEXAS syndrome
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
January 24, 2022
Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review
Sara Bindoli, Alessandro Giollo, Paola Galozzi, et al.
Expert Review of Clinical Immunology
|
January 21, 2020
Canakinumab for the treatment of adult-onset Still's disease
Paolo Sfriso, Sara Bindoli, Andrea Doria, et al.
Frontiers in Pharmacology
|
October 10, 2018
Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease
Paola Galozzi, Chiara Baggio, Sara Bindoli, et al.
Journal of Clinical Medicine
|
April 30, 2021
Autoinflammatory Features in Gouty Arthritis
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Page
of 5